TrialBlood2008

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

Drew J Winston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.